| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/12/2008 | WO2008008224A3 Sour taste receptor compositions and methods |
| 06/12/2008 | WO2007117258A3 Growth of wild-type hepatitis a virus in cell culture |
| 06/12/2008 | WO2007075592A3 Materials and methods for treating chronic fibrotic disease |
| 06/12/2008 | WO2007055823A3 Gpcr expressing cell lines and antibodies |
| 06/12/2008 | US20080141392 Genetic Constructs Having Heterologous 3' Polyadenylation Signal Sequence Motifs that Function in Plants |
| 06/12/2008 | US20080141390 Nucleic acid construct comprising promoter and terminator sequence coupled to permit transcription; transgenic corn |
| 06/12/2008 | US20080141389 Transgenic cell transformed with polynucleotide to increase drought tolerance |
| 06/12/2008 | US20080141388 Cell-Cycle Stress-Related Proteins and Methods of Use in Plants |
| 06/12/2008 | US20080141387 Protein Production |
| 06/12/2008 | US20080141385 Determining if compound is activator or inhibitor of oxidative stress response by detecting expression of transgene in nematode; screening for antioxidants |
| 06/12/2008 | US20080140451 Devices and Methods for Monitoring, Managing, and Servicing Medical Devices |
| 06/12/2008 | US20080139659 Reducing intracranial pressure with sulfonylurea receptor 1 antagonist |
| 06/12/2008 | US20080139632 Such as 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-2-hydroxybenzoic acid for modulating premature translation termination or nonsense-mediated mRNA decay in cells |
| 06/12/2008 | US20080139620 Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's |
| 06/12/2008 | US20080139596 Modulators of Hcv Replication |
| 06/12/2008 | US20080139580 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 06/12/2008 | US20080139557 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors |
| 06/12/2008 | US20080139546 e.g. 3-(3,4-dihydroquinolin-1(2H)-yl)-N-{[8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinolin-2-yl]methyl}propan-1-amine; modulators of serotonin 5-HT1A receptor activity and/or serotonin reuptake; antidepressant, anxiolytic agent, cognition activator; schizophrenia, sexual disorders |
| 06/12/2008 | US20080139492 Nucleobase oligomeric compositions useful in enhancing RNA interference in a wide variety of cell types for treatment of virtually any disease or disorder related to overexpression of a gene or genes, as well as methods of identifying and using such compositions |
| 06/12/2008 | US20080139477 Introduced DNA sequences are replicated, stably retained and segregated independent of continuous selection pressure |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139467 Method and Products For the Selective Degradation of Proteins |
| 06/12/2008 | US20080139466 Dna Sequence and Expressed Recombinant Glycoproteins Related to Feline Thyrotropin |
| 06/12/2008 | US20080139464 Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof |
| 06/12/2008 | US20080139402 Cell-based detection and differentiation of disease states |
| 06/12/2008 | US20080139400 Molecular display on multimeric protein scaffolds |
| 06/12/2008 | US20080138903 Regulating metabolism by modifying the level of trehalose-6-phosphate |
| 06/12/2008 | US20080138901 Nucleotide having encapsidation signal and lacking overlapping sequences with nucleic acid of cell; safe large scale production; replication-defective |
| 06/12/2008 | US20080138900 Cell-retaining cavities having adhesive bottom surface; uniform shape and size; can culture for long periods of time |
| 06/12/2008 | US20080138899 Destroying cell expressing polypeptide of given sequence by contacting with cytotoxic immunoconjugate; ricin, doxorubicin; treatment and detection of prostate cancer metastasis |
| 06/12/2008 | US20080138898 Substituting amino acids in variable region framework sequence comprising heavy and light chains; higher yield |
| 06/12/2008 | US20080138897 Method for preventing HIV-1 infection of CD4+ Cells |
| 06/12/2008 | US20080138896 Methods for Inhibiting Melanocyte Stem Cell Loss |
| 06/12/2008 | US20080138895 Cultures of gfap+ nestin+ cells that differentiate to neurons |
| 06/12/2008 | US20080138894 Recombinant expression in eukaryotic or mammalian cells using vectors; cleavage and site-directed mutagenesis |
| 06/12/2008 | US20080138893 Optimizing Expression Of Active BotulinumToxin Type E |
| 06/12/2008 | US20080138848 Microfluidic Device and Method of Using Same |
| 06/12/2008 | US20080138847 Bcl-2 family member and BH-3 only proteins for use in development of peptidomimetics |
| 06/12/2008 | US20080138828 Continuously propagating plant material in hydrofocusing bioreactor |
| 06/12/2008 | US20080138820 Cell comprising reporter gene construct encoding fluorescent protein fused to centromere protein A, and second reporter gene construct encoding nitroreductase |
| 06/12/2008 | US20080138818 Gene reporter assay, kit and cells with improved sensitivity and/or specificity for determining the level of an extracellular signal |
| 06/12/2008 | US20080138814 Compositions and Methods for Modulation of KSR1 and KSR2 Interactions |
| 06/12/2008 | US20080138811 Tissue-Based Assay System for Alzheimer-Specific Degeneration and Pathology |
| 06/12/2008 | US20080138805 Using microneedle filled with a porous matrix comprising a chemotactic factor to isolate migrating cells in tissue mass; using microbeads comprisng cell specific binding agents to remove unwanted migating cell; screening antitumor agents |
| 06/12/2008 | US20080138797 Apparatus comprising piezoelectric substrate surface-modified with a binding agent for use in detection of microorganisms |
| 06/12/2008 | US20080138794 Method for detecting or measuring HBV |
| 06/12/2008 | US20080138416 Method and systems for using biopolymer-based beads and hydrogels |
| 06/12/2008 | US20080138415 Composition and method for producing composition for constructing tissue, and tissue construct |
| 06/12/2008 | US20080138379 Preventing birth defects; administering formulation to women from preconception through first trimester of pregnancy |
| 06/12/2008 | US20080138378 Cell seeded expandable body |
| 06/12/2008 | US20080138362 Cell Strain Capable of Being Cultured Without Ingredients Derived From Animals, Method of Producing the Same, Method of Producing Virus Using the Same, and Method of Producing Vaccine |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |
| 06/12/2008 | US20080138355 Modified leukotoxin gene and protein |
| 06/12/2008 | US20080138354 Adeno-associated viral vector comprising nucleic acids coding modified nuclear localization signal sequences for use in vaccination against viral infection; genetic vaccines |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | US20080138344 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same |
| 06/12/2008 | US20080138336 Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease |
| 06/12/2008 | US20080138335 Stabilized Human IgG2 And IgG3 Antibodies |
| 06/12/2008 | US20080138325 Using microprojectiles comprising immobilized polynucleotide sequences as gene transfer agents |
| 06/12/2008 | US20080138319 Stem cell tissue for use in treatment of nervous system disorders; tissue engineering; regenerative medicine |
| 06/12/2008 | US20080138276 Monoclonal antibody produced by hybridoma with IDAC accession number 180706-02; competitive binding of monoclonal antibody, humanized-, chimeric- or cancerous disease modifying antibodies (CDMAB) with tissue sample induces cytotoxicity; anticarcinogenic, antitumor, and antimetastasis agents; diagnosis |
| 06/12/2008 | US20080138275 Hybridoma cell line G250 and its use for producing monoclonal antibodies |
| 06/12/2008 | DE102007040252A1 Device for electronically flow-controlled distribution of tissue regenerating cell in sterile suspension across an area for further growth comprises electronically pressure/flow controlled spray head enabling controlled pump driven spraying |
| 06/12/2008 | CA2678695A1 Three-dimensional tissue equivalent using macromass culture |
| 06/12/2008 | CA2674217A1 Regulation of plant metabolism |
| 06/12/2008 | CA2671425A1 Method for modifying insect resistance of plants by utilizing rnai technique |
| 06/12/2008 | CA2671365A1 Novel selectable marker genes |
| 06/12/2008 | CA2667058A1 Process for the enrichment of melanocytes by means of modified surfaces |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930434A1 Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof |
| 06/11/2008 | EP1930433A1 T-cell receptor and nucleic acid encoding the receptor |
| 06/11/2008 | EP1930430A1 Method for specifically selecting antibody-producing cell |
| 06/11/2008 | EP1930429A1 Msx1/2, MARKERS OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 06/11/2008 | EP1930425A1 Sequence capable of enhancing the expression of gene under moderately low temperature |
| 06/11/2008 | EP1930424A1 Novel apoptosis inducing factor and method of inducing apoptosis using the same |
| 06/11/2008 | EP1930423A1 Expression vector, transformant having the expression vector introduced therein, and process for production of heterologous protein |
| 06/11/2008 | EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 06/11/2008 | EP1930418A1 Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| 06/11/2008 | EP1930415A1 Development of method for screening of compound capable of improving the production of regulatory t cell, and method for production of regulatory t cell using immunosuppressive macrolide antibiotic |
| 06/11/2008 | EP1930414A1 Method for activation treatment of antigen-presenting cell |
| 06/11/2008 | EP1930413A1 Technique for culture of mesenchymal stem cell utilizing laminin-5 |
| 06/11/2008 | EP1930412A1 Neural stem cell medium and differentiation method |
| 06/11/2008 | EP1930411A1 Three dimensional tissue equivalent using macromass culture |
| 06/11/2008 | EP1930026A1 A method for generating birnavirus from synthetic RNA transcripts |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1929306A2 Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics |
| 06/11/2008 | EP1929034A1 Cancerous disease modifying antibodies |
| 06/11/2008 | EP1929033A1 Cancerous disease modifying antibodies |
| 06/11/2008 | EP1929032A2 Regulation of toll-like receptors on stem cells |
| 06/11/2008 | EP1929022A2 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport |
| 06/11/2008 | EP1929020A2 Dsrna as insect control agent |
| 06/11/2008 | EP1929006A1 Activating agent of stem cells and/or progenitor cells |
| 06/11/2008 | EP1928999A2 Methods of producing stable b-lymphocytes |
| 06/11/2008 | EP1928598A1 Reactor comprising an annular reaction space |
| 06/11/2008 | EP1928513A2 Cell delivery fluid for prevention of cellsettling in delivery system |
| 06/11/2008 | EP1928488A1 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 06/11/2008 | EP1928487A2 A novel peptide involved in energy homeostasis |
| 06/11/2008 | EP1928479A2 Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance |